These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors. Liu FZ, Fang H, Zhu HW, Wang Q, Yang Y, Xu WF. Bioorg Med Chem; 2008 Jan 01; 16(1):578-85. PubMed ID: 17937988 [Abstract] [Full Text] [Related]
23. Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads. Kotthaus J, Schade D, Muschick N, Beitz E, Clement B. Bioorg Med Chem; 2008 Dec 15; 16(24):10205-9. PubMed ID: 19013076 [Abstract] [Full Text] [Related]
34. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. Ichimori K, Stuehr DJ, Atkinson RN, King SB. J Med Chem; 1999 May 20; 42(10):1842-8. PubMed ID: 10346937 [Abstract] [Full Text] [Related]
35. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. Tang Q, Svensson CI, Fitzsimmons B, Webb M, Yaksh TL, Hua XY. Eur J Neurosci; 2007 May 20; 25(10):2964-72. PubMed ID: 17561811 [Abstract] [Full Text] [Related]
36. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. Kankuri E, Vaali K, Knowles RG, Lähde M, Korpela R, Vapaatalo H, Moilanen E. J Pharmacol Exp Ther; 2001 Sep 20; 298(3):1128-32. PubMed ID: 11504810 [Abstract] [Full Text] [Related]
37. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice. Nemec A, Pavlica Z, Petelin M, Crossley DA, Sentjurc M, Jerin A, Erzen D, Zdovc I, Hitti T, Skaleric U. Arch Oral Biol; 2010 Jul 20; 55(7):509-14. PubMed ID: 20430367 [Abstract] [Full Text] [Related]
38. Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors. Wu Z, Yang C, Graham TH, Verras A, Chabin RM, Xu S, Tong X, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Shen Z, Chen Q, Bleasby K, Sinharoy R, Hale JJ, Tata JR, Pinto S, Colletti SL, Shen DM. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1727-30. PubMed ID: 22290078 [Abstract] [Full Text] [Related]
39. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors. Litzinger EA, Martásek P, Roman LJ, Silverman RB. Bioorg Med Chem; 2006 May 01; 14(9):3185-98. PubMed ID: 16431112 [Abstract] [Full Text] [Related]
40. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors. Ueda S, Terauchi H, Yano A, Matsumoto M, Kubo T, Kyoya Y, Suzuki K, Ido M, Kawasaki M. Bioorg Med Chem; 2004 Aug 01; 12(15):4101-16. PubMed ID: 15246088 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]